MXPA05004507A - 4-amino-1-(piridilmetil)piperidina sustituida como antagonista del receptor muscarinico. - Google Patents
4-amino-1-(piridilmetil)piperidina sustituida como antagonista del receptor muscarinico.Info
- Publication number
- MXPA05004507A MXPA05004507A MXPA05004507A MXPA05004507A MXPA05004507A MX PA05004507 A MXPA05004507 A MX PA05004507A MX PA05004507 A MXPA05004507 A MX PA05004507A MX PA05004507 A MXPA05004507 A MX PA05004507A MX PA05004507 A MXPA05004507 A MX PA05004507A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- pyridylmethyl
- piperidine
- amino
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
Esta invencion proporciona la 4-amino-1-(piridilmetil) piperidina de la formula (I) y compuestos relacionados y sales farmaceuticamente aceptables de los mismos, los cuales son utiles como antagonistas de receptores muscarinicos. Esta invencion tambien proporciona composiciones farmaceuticas que contienen estos compuestos; procedimientos y productos intermediarios para preparar estos compuestos; y metodos para el tratamiento de condiciones de enfermedad mediadas por los receptores muscarinicos, tales como la vejiga hiperactiva, sindrome del intestino irritable y enfermedad pulmonar obstructiva, cronica, utilizando estos compuestos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42222902P | 2002-10-30 | 2002-10-30 | |
US48648303P | 2003-07-11 | 2003-07-11 | |
PCT/US2003/034444 WO2004041806A2 (en) | 2002-10-30 | 2003-10-29 | Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05004507A true MXPA05004507A (es) | 2005-10-18 |
Family
ID=32314442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05004507A MXPA05004507A (es) | 2002-10-30 | 2003-10-29 | 4-amino-1-(piridilmetil)piperidina sustituida como antagonista del receptor muscarinico. |
Country Status (20)
Country | Link |
---|---|
US (2) | US7285564B2 (es) |
EP (1) | EP1556372B1 (es) |
JP (2) | JP4448492B2 (es) |
KR (1) | KR20050061504A (es) |
AR (1) | AR041855A1 (es) |
AT (1) | ATE363482T1 (es) |
AU (1) | AU2003285100A1 (es) |
BR (1) | BR0315778A (es) |
CA (1) | CA2500800A1 (es) |
DE (1) | DE60314170T2 (es) |
EC (1) | ECSP055762A (es) |
ES (1) | ES2287543T3 (es) |
IS (1) | IS7780A (es) |
MX (1) | MXPA05004507A (es) |
NO (1) | NO20052521L (es) |
PE (1) | PE20040606A1 (es) |
PL (1) | PL376716A1 (es) |
RU (1) | RU2005116239A (es) |
TW (2) | TW200800953A (es) |
WO (1) | WO2004041806A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200800953A (en) * | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
TW200510298A (en) | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
US7368463B2 (en) * | 2003-07-11 | 2008-05-06 | Theravance, Inc. | Substituted 4-amino-1-benzylpiperidine compounds |
PE20050973A1 (es) * | 2003-10-29 | 2005-11-19 | Theravance Inc | Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos |
WO2005087722A1 (en) * | 2004-03-11 | 2005-09-22 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
EP1723142A1 (en) * | 2004-03-11 | 2006-11-22 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
TW200540154A (en) * | 2004-06-10 | 2005-12-16 | Theravance Inc | Crystalline form of a substituted pyrrolidine compound |
TW200628465A (en) * | 2004-10-28 | 2006-08-16 | Theravance Inc | Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds |
US7880007B2 (en) * | 2004-11-29 | 2011-02-01 | Vertex Pharmaceuticals Incorporated | Bicyclic substituted phenyl piperidine modulators of muscarinic receptors |
EP1863490A2 (en) * | 2005-03-28 | 2007-12-12 | Vertex Pharmaceuticals Incorporated | Muscarinic modulators |
BRPI0807615A8 (pt) * | 2007-02-23 | 2017-12-05 | Theravance Inc | Compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico |
WO2009153649A1 (en) * | 2008-06-19 | 2009-12-23 | Medichem, S.A. | Process for preparing 3-substituted pyrrolidine compounds |
NZ599233A (en) * | 2009-10-07 | 2013-04-26 | Merck Sharp & Dohme | Combination therapy using a beta 3 adrenergic receptor agonist and an antimuscarinic agent |
WO2011143457A2 (en) | 2010-05-12 | 2011-11-17 | Northwestern University | Compositions and methods for treating or preventing atrial fibrillation |
US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
MX353105B (es) | 2010-08-03 | 2017-12-19 | Velicept Therapeutics Inc | Combinaciones de agonistas del receptor beta-3-adrenergico y antagonistas del receptor muscarinico para tratar vejiga hiperactiva. |
US9522129B2 (en) | 2010-08-03 | 2016-12-20 | Velicept Therapeutics, Inc. | Pharmaceutical Combination |
EP2811989A1 (en) * | 2012-02-09 | 2014-12-17 | Altherx Inc. | Combination of muscarinic receptor antagonists and beta- 3 adrenoceptor agonists for treating overactive bladder |
AU2015358378A1 (en) | 2014-12-03 | 2017-06-29 | Velicept Therapeutics, Inc. | Compositions and methods of using modified release solabegron for lower urinary tract symptoms |
PT3365321T (pt) | 2015-10-23 | 2024-01-12 | B3Ar Therapeutics Inc | Zwiterião de solabegron e suas utilizações |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3192221A (en) * | 1961-12-04 | 1965-06-29 | Robins Co Inc A H | 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones and production thereof |
US3192210A (en) * | 1961-12-04 | 1965-06-29 | Robins Co Inc A H | 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones |
US3192206A (en) * | 1961-12-04 | 1965-06-29 | Robins Co Inc A H | 4-(omega-aminoalkyl)-3, 3-disubstitutedn-hydrocarbon-2-pyrrolidinones and corresponding-2-thionpyrrolidinones |
GB1507462A (en) | 1974-03-21 | 1978-04-12 | Gallardo Antonio Sa | N-heterocyclic substituted benzamides methods for their preparation and compositions containing them |
GB1593851A (en) | 1976-10-27 | 1981-07-22 | Gallardo Antonio Sa | N-(4-piperidyl)-benzamides and pharmaceutical compositions containing them |
US4002766A (en) * | 1974-12-26 | 1977-01-11 | A. H. Robins Company, Incorporated | Antiarrhythmia methods |
US3984557A (en) * | 1974-12-26 | 1976-10-05 | A. H. Robins Company, Incorporated | Antiarrhythmia compositions and methods |
GB1575310A (en) | 1976-11-16 | 1980-09-17 | Anphar Sa | Piperidine derivatives |
GB1574418A (en) * | 1976-11-16 | 1980-09-03 | Anphar Sa | Piperidine derivatives |
CH628885A5 (en) | 1978-01-01 | 1982-03-31 | Anphar Sa | Piperidine derivative |
US4594343A (en) * | 1984-10-19 | 1986-06-10 | Shanklin Jr James R | 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles |
IL76583A (en) | 1984-10-19 | 1988-08-31 | Robins Co Inc A H | 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them |
US4810713A (en) * | 1985-12-20 | 1989-03-07 | A. H. Robins Company, Incorporated | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment |
EP0235463A3 (en) | 1985-12-20 | 1990-01-17 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents |
US5932594A (en) * | 1988-11-01 | 1999-08-03 | Pfizer, Inc. | Muscarinic receptor antagonists |
US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
GB8906166D0 (en) | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
US5070087A (en) * | 1989-05-08 | 1991-12-03 | A. H. Robins Company, Incorporated | Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents |
US5028616A (en) * | 1989-09-05 | 1991-07-02 | G. D. Searle & Co. | N-benzylpiperidine amides |
US5281601A (en) * | 1989-12-12 | 1994-01-25 | Pfizer Inc. | Muscarinic receptor antagonists |
GB8928042D0 (en) * | 1989-12-12 | 1990-02-14 | Pfizer Ltd | Muscarinic receptor antagonists |
US5607950A (en) * | 1990-01-06 | 1997-03-04 | Pfizer Inc. | Muscarinic receptor antagonists |
US5486527A (en) * | 1990-01-06 | 1996-01-23 | Pfizer Inc. | Anticholinergic agents |
GB9000301D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Piperidine & pyrrolidine derivatives |
AU700837B2 (en) * | 1995-04-28 | 1999-01-14 | Banyu Pharmaceutical Co., Ltd. | 1,4-di-substituted piperidine derivatives |
WO1997013766A1 (fr) | 1995-10-13 | 1997-04-17 | Banyu Pharmaceutical Co., Ltd. | Derives heteroaromatiques substitues |
PE92198A1 (es) | 1996-08-01 | 1999-01-09 | Banyu Pharma Co Ltd | Derivados de 1,4-piperidina disustituida que contienen fluor |
WO1999005095A1 (fr) | 1997-07-24 | 1999-02-04 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Composes d'aminocycloalcane |
CN1270582A (zh) | 1997-09-18 | 2000-10-18 | 三菱东京制药株式会社 | 咪唑啉化合物 |
US6319920B1 (en) * | 1998-02-27 | 2001-11-20 | Syntex (U.S.A.) Llc | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives |
WO1999064043A1 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Muscarinic receptor antagonists |
US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
MXPA02005596A (es) * | 1999-12-07 | 2004-09-10 | Theravance Inc | Derivados de carbamato con actividad antagonista para el rerceptor muscarinico. |
UA73543C2 (uk) * | 1999-12-07 | 2005-08-15 | Тераванс, Інк. | Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором |
IL156499A0 (en) | 2000-12-22 | 2004-01-04 | Almirall Prodesfarma Ag | Quinuclidine carbamate derivatives and their use as m3 antagonists |
SK287414B6 (sk) | 2000-12-28 | 2010-09-07 | Laboratorios Almirall, S.A. | Chinuklidínové deriváty a kompozície s ich obsahom |
JP4353803B2 (ja) | 2001-12-03 | 2009-10-28 | エフ.ホフマン−ラ ロシュ アーゲー | ムスカリン受容体アンタゴニストとしての4−ピペリジニルアルキルアミン誘導体 |
TW200800953A (en) | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
EP1615881A2 (en) | 2003-04-01 | 2006-01-18 | Theravance, Inc. | Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TW200510298A (en) | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
US7368463B2 (en) * | 2003-07-11 | 2008-05-06 | Theravance, Inc. | Substituted 4-amino-1-benzylpiperidine compounds |
PE20050973A1 (es) | 2003-10-29 | 2005-11-19 | Theravance Inc | Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos |
EP1723142A1 (en) | 2004-03-11 | 2006-11-22 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
WO2005087722A1 (en) | 2004-03-11 | 2005-09-22 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
TW200540154A (en) | 2004-06-10 | 2005-12-16 | Theravance Inc | Crystalline form of a substituted pyrrolidine compound |
TW200628465A (en) | 2004-10-28 | 2006-08-16 | Theravance Inc | Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds |
-
2003
- 2003-10-23 TW TW096104840A patent/TW200800953A/zh unknown
- 2003-10-23 TW TW092129422A patent/TWI295669B/zh not_active IP Right Cessation
- 2003-10-28 PE PE2003001087A patent/PE20040606A1/es not_active Application Discontinuation
- 2003-10-29 CA CA002500800A patent/CA2500800A1/en not_active Abandoned
- 2003-10-29 AU AU2003285100A patent/AU2003285100A1/en not_active Abandoned
- 2003-10-29 RU RU2005116239/04A patent/RU2005116239A/ru not_active Application Discontinuation
- 2003-10-29 WO PCT/US2003/034444 patent/WO2004041806A2/en active IP Right Grant
- 2003-10-29 JP JP2005502211A patent/JP4448492B2/ja not_active Expired - Lifetime
- 2003-10-29 AR ARP030103949A patent/AR041855A1/es unknown
- 2003-10-29 DE DE60314170T patent/DE60314170T2/de not_active Expired - Lifetime
- 2003-10-29 BR BR0315778-4A patent/BR0315778A/pt not_active IP Right Cessation
- 2003-10-29 US US10/696,464 patent/US7285564B2/en active Active
- 2003-10-29 AT AT03779416T patent/ATE363482T1/de not_active IP Right Cessation
- 2003-10-29 MX MXPA05004507A patent/MXPA05004507A/es active IP Right Grant
- 2003-10-29 ES ES03779416T patent/ES2287543T3/es not_active Expired - Lifetime
- 2003-10-29 EP EP03779416A patent/EP1556372B1/en not_active Expired - Lifetime
- 2003-10-29 KR KR1020057005627A patent/KR20050061504A/ko not_active Application Discontinuation
- 2003-10-29 PL PL376716A patent/PL376716A1/pl unknown
-
2005
- 2005-03-31 IS IS7780A patent/IS7780A/is unknown
- 2005-04-27 EC EC2005005762A patent/ECSP055762A/es unknown
- 2005-05-25 NO NO20052521A patent/NO20052521L/no unknown
-
2007
- 2007-10-17 US US11/974,982 patent/US8030502B2/en active Active
-
2009
- 2009-12-16 JP JP2009285737A patent/JP2010059214A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP4448492B2 (ja) | 2010-04-07 |
US7285564B2 (en) | 2007-10-23 |
US20040122014A1 (en) | 2004-06-24 |
BR0315778A (pt) | 2005-09-06 |
ECSP055762A (es) | 2005-07-06 |
KR20050061504A (ko) | 2005-06-22 |
TW200418833A (en) | 2004-10-01 |
NO20052521L (no) | 2005-05-25 |
PL376716A1 (pl) | 2006-01-09 |
US20080091034A1 (en) | 2008-04-17 |
ES2287543T3 (es) | 2007-12-16 |
EP1556372B1 (en) | 2007-05-30 |
PE20040606A1 (es) | 2004-09-08 |
IS7780A (is) | 2005-03-31 |
TW200800953A (en) | 2008-01-01 |
WO2004041806A2 (en) | 2004-05-21 |
DE60314170D1 (de) | 2007-07-12 |
JP2010059214A (ja) | 2010-03-18 |
ATE363482T1 (de) | 2007-06-15 |
US8030502B2 (en) | 2011-10-04 |
RU2005116239A (ru) | 2006-01-27 |
TWI295669B (en) | 2008-04-11 |
AR041855A1 (es) | 2005-06-01 |
AU2003285100A1 (en) | 2004-06-07 |
DE60314170T2 (de) | 2008-01-24 |
CA2500800A1 (en) | 2004-05-21 |
WO2004041806A3 (en) | 2004-08-05 |
JP2006512408A (ja) | 2006-04-13 |
EP1556372A2 (en) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05004507A (es) | 4-amino-1-(piridilmetil)piperidina sustituida como antagonista del receptor muscarinico. | |
WO2004048330A8 (en) | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them | |
EA200601266A1 (ru) | Соединения триазола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
NO20064065L (no) | Diaminopyrimidiner som P2X3 og P2X2/3 antagonister | |
NO20072371L (no) | Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister | |
SI1856090T1 (sl) | Substituirani derivati tiofena kot antagonisti glukagonskega receptorja, priprava in terapevtske uporabe | |
RU2007129090A (ru) | Органические соединения | |
WO2006041985A3 (en) | Thienopyridinone compounds and methods of treatment | |
MY153719A (en) | Prokineticin 1 receptor antagonists | |
EA200701324A1 (ru) | Соединения пиридина для лечения заболеваний, опосредованных действием простагландина | |
IS8377A (is) | Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns | |
TW200716566A (en) | Prokineticin 2 receptor antagonists | |
NO20060191L (no) | 1-(alkylaminoalkyl-pyrolidin-/piperidinyl)2,2-difenylacetamidderivater som muskarinreceptoragonister | |
WO2007127196A3 (en) | DIALKYLPHENYL COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY | |
EA200702612A1 (ru) | Соединения бензимидазолкарбоксамида в качестве агонистов рецепторов 5-нт | |
EA201001645A1 (ru) | Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора | |
CY1109694T1 (el) | Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης | |
NO20084674L (no) | 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser | |
NO20063562L (no) | Fusjonerte heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
EA200501594A1 (ru) | Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора | |
JP2005104896A (ja) | 2−アルコキシ−6−アミノ−5−ハロゲノピリジン−3−カルボキサミド誘導体およびそれを含有する医薬組成物 | |
JP2005082508A (ja) | 2−アルコキシ−6−アミノ−5−ハロゲノ−n−(1−置換−4−ピペリジニル)ピリジン−3−カルボキサミド誘導体およびそれを含有する医薬組成物 | |
UA99521C2 (ru) | Хинуклидин-производные как антагонисты мускариновых рецепторов м3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights |